Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Scientific Reports|December 31, 2024
The effects of high-intensity interval training on cognitive performance: a systematic review and meta-analysisKaihang Liu, Wei Zhao, Congcong Li, et al.
Frontiers in Oncology|October 3, 2022
Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lungHongbiao Wang, Jun Liu, Sujuan Zhu, et al.
Annals of Hematology|July 16, 2024
Circulating tumor DNA assisting lymphoma genetic feature profiling and identificationHongbiao Wang, Zhao Wang, Sujuan Zhu, et al.
Frontiers in Pediatrics|August 30, 2021
Nomogram for Predicting Bone Development State of Female Children and Adolescents-A Fast Screening Approach Based on Pubes Stages for Growth and DevelopmentRuoyu Yang, Liyan Wang, Chao Wu, et al.
Analytical Chemistry|November 23, 2022
Covalent Bonding and Coulomb Repulsion-Guided AuNP Array: A Tunable and Reusable Substrate for Metabolomic Characterization of Lung Cancer Patient SeraYang Su, Xiaopin Lai, Kunbin Guo, et al.
Nanoscale|April 11, 2024
Hierarchical superstructure aerogels for in situ biofluid metabolomicsSiyu Chen, Keyuan Pu, Yue Wang, et al.
Analytical Methods : Advancing Methods and Applications|January 4, 2022
Combining MALDI-MS with machine learning for metabolomic characterization of lung cancer patient seraXiaopin Lai, Kunbin Guo, Wei Huang, et al.
Lancet (London, England)|May 31, 2026
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in ChinaShun Lu, Baogang Liu, Yongzhong Luo, et al.
Lancet (London, England)|October 22, 2025
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trialZhiwei Chen, Fang Yang, Zhou Jiang, et al.
Pageof 5